- Home
- DXLG vs NNVC Comparison
DXLG vs NNVC Comparison
Compare DXLG & NNVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DXLG | NNVC |
|---|---|---|
| Founded | 1976 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.0M | 37.9M |
| IPO Year | 1994 | 2008 |
Fundamental Metrics
Financial Performance| Metric | DXLG | NNVC |
|---|---|---|
| Price | $0.62 | $1.72 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $1.50 | N/A |
| AVG Volume (30 Days) | 67.8K | ★ 349.7K |
| Earning Date | 05-28-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 10.00 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $435,017,000.00 | N/A |
| Revenue This Year | $3.85 | N/A |
| Revenue Next Year | $4.09 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.44 | $0.85 |
| 52 Week High | $1.69 | $2.23 |
Technical Indicators
Market Signals| Indicator | DXLG | NNVC |
|---|---|---|
| Relative Strength Index (RSI) | 39.92 | 62.04 |
| Support Level | $0.62 | $1.16 |
| Resistance Level | $0.72 | $1.90 |
| Average True Range (ATR) | 0.04 | 0.13 |
| MACD | -0.00 | 0.04 |
| Stochastic Oscillator | 12.36 | 80.36 |
Price Performance
Historical ComparisonAbout DXLG Destination XL Group Inc.
Destination XL Group Inc is a retailer of branded and Tall men's clothing and shoes in the United States. It also sells products across the world. The company sells its products under the trade names Destination XL, DXL, DXL Men's Apparel, DXL outlets, Casual Male XL, and Casual Male XL outlets. The company has two principal operating segments: Store and Direct business. The company have two principal operating segments: company's stores and direct business.
About NNVC NanoViricides Inc.
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.